SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-051109
Filing Date
2024-12-20
Accepted
2024-12-20 17:15:33
Documents
14
Period of Report
2024-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44701
2 ex10-1.htm EX-10.1 33597
  Complete submission text file 0001493152-24-051109.txt   262671

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fblg-20241219.xsd EX-101.SCH 3033
4 XBRL LABEL FILE fblg-20241219_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE fblg-20241219_pre.xml EX-101.PRE 24177
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3810
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41934 | Film No.: 241568935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)